A phase II study of the safety and efficacy of the multidrug resistance inhibitor VX-710 combined with doxorubicin and vincristine in patients with recurrent small cell lung cancer

Leena Gandhi, Matthew W. Harding, Marcus Neubauer, Corey J. Langer, Melvin Moore, Helen J. Ross, Bruce E. Johnson, Thomas J. Lynch

Research output: Contribution to journal › Article › peer-review

68 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II study of the safety and efficacy of the multidrug resistance inhibitor VX-710 combined with doxorubicin and vincristine in patients with recurrent small cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences